ConductScience.org, home

Paper7731985

Mutagenesis of the putative alpha-helical domain of the Vpr protein of human immunodeficiency virus type 1: effect on stability and virion incorporation.

Mahalingam S and 6 others. Proc Natl Acad Sci U S A, 1995. Cited by 69 papers, by iCite.

Cite this record

ConductScience Library. Mutagenesis of the putative alpha-helical domain of the Vpr protein of human immunodeficiency virus type 1: effect on stability and virion incorporation. Papers, record 7731985. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/7731985

Download JSON
Sources
11 sources
Release
papers-2026-11-12-0.1.0

Paper

PubMed's record of the paper, with iCite's citation figures. No abstract is shown.

Title
Mutagenesis of the putative alpha-helical domain of the Vpr protein of human immunodeficiency virus type 1: effect on stability and virion incorporation.
PubMed
Journal
Proc Natl Acad Sci U S A
PubMed
Year
1995
PubMed
Publication types
Comparative Study, Journal Article, Research Support, Non-U.S. Gov't, Research Support, U.S. Gov't, P.H.S.
PubMed
Citations, by iCite
69
iCite
Relative citation ratio, by iCite
1.39
iCite
Revised in PubMed
2019-05-01
PubMed

Authors7

The authors in the order PubMed's record lists them, with the ORCID iDs it states.

OrderAuthorForenameKindORCID iD
1Mahalingam SS
2Khan SAS A
3Murali RR
4Jabbar MAM A
5Monken CEC E
6Collman RGR G
7Srinivasan AA

Source PubMed

Download CSV of authors

Topics16

NLM's MeSH indexing of the paper, its major topics first.

MeSH termMajor
Gene Products, vprMajor topic
HIV-1Major topic
Protein Structure, SecondaryMajor topic
VirionMajor topic
Amino Acid Sequence
Aspartic Acid
Drug Stability
Genes, vpr
Glutamic Acid
HeLa Cells
Humans
Molecular Sequence Data
Mutagenesis, Site-Directed
Recombinant Proteins
Transfection
vpr Gene Products, Human Immunodeficiency Virus

Source PubMed

Download CSV of topics

Grants4

Each grant PubMed's record writes, matched to the NIH project NIH's grant and paper links name for this paper, and each of those links the record does not write.

Grant, as the record writes itAgencyCountryNIH projectStated bySource
AI29306NIAID NIH HHSUnited StatesR01AI029306PubMed and NIHNIH RePORTER
AI35502NIAID NIH HHSUnited StatesR01AI035502PubMed and NIHNIH RePORTER
MH10035NIMH NIH HHSUnited StatesF32MH010035PubMed and NIHNIH RePORTER
R29AI035502NIHNIH RePORTER

Download CSV of grants

References42

The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.

OrderPMIDTitleJournalYearIn PapersSource
16048867Use of helical wheels to represent the structures of proteins and to identify segments with helical potential.Biophys J1967https://conductscience.org/library/papers/6048867PubMed
28195203Biochemical mechanism of HIV-I Vpr function. Specific interaction with a cellular protein.J Biol Chem1994https://conductscience.org/library/papers/8195203PubMed
33943133Targeting of pre-ornithine transcarbamylase to mitochondria: definition of critical regions and residues in the leader peptide.Cell1986https://conductscience.org/library/papers/3943133PubMed
43112559Use of a hybrid vaccinia virus-T7 RNA polymerase system for expression of target genes.Mol Cell Biol1987https://conductscience.org/library/papers/3112559PubMed
53476127Human immunodeficiency virus: the eighth gene.AIDS Res Hum Retroviruses1987https://conductscience.org/library/papers/3476127PubMed
63360744
Statistical and functional analyses of viral and cellular proteins with N-terminal amphipathic alpha-helices with large hydrophobic moments: importance to macromolecular recognition and organelle targeting.
J Bacteriol1988https://conductscience.org/library/papers/3360744PubMed
73388031Isolation and characterization of a novel protein (X-ORF product) from SIV and HIV-2.Science1988https://conductscience.org/library/papers/3388031PubMed
82524599Viral protein R of human immunodeficiency virus types 1 and 2 is dispensable for replication and cytopathogenicity in lymphoid cells.J Virol1989https://conductscience.org/library/papers/2524599PubMed
92744487Site-directed mutagenesis by overlap extension using the polymerase chain reaction.Gene1989https://conductscience.org/library/papers/2744487PubMed
108041786The Vpr protein of human immunodeficiency virus type 1 influences nuclear localization of viral nucleic acids in nondividing host cells.Proc Natl Acad Sci U S A1994https://conductscience.org/library/papers/8041786PubMed
117871742Identification of residues in the N-terminal acidic domain of HIV-1 Vpr essential for virion incorporation.Virology1995https://conductscience.org/library/papers/7871742PubMed
122474678Mutational analysis of the human immunodeficiency virus vpr open reading frame.J Virol1989https://conductscience.org/library/papers/2474678PubMed
132136707Identification of HIV-1 vpr product and function.J Acquir Immune Defic Syndr (1988)1990https://conductscience.org/library/papers/2136707PubMed
142139896Human immunodeficiency virus vpr product is a virion-associated regulatory protein.J Virol1990https://conductscience.org/library/papers/2139896PubMed
152235991Amphipathic helix motif: classes and properties.Proteins1990https://conductscience.org/library/papers/2235991PubMed
162236020The human immunodeficiency virus type 2 vpr gene is essential for productive infection of human macrophages.Proc Natl Acad Sci U S A1990https://conductscience.org/library/papers/2236020PubMed
171995941Human immunodeficiency virus as a prototypic complex retrovirus.J Virol1991https://conductscience.org/library/papers/1995941PubMed
181825343Rev activates expression of the human immunodeficiency virus type 1 vif and vpr gene products.J Virol1991https://conductscience.org/library/papers/1825343PubMed
192150318Human immunodeficiency virus vpr gene encodes a virion-associated protein.AIDS Res Hum Retroviruses1990https://conductscience.org/library/papers/2150318PubMed
201827422Rev is necessary for translation but not cytoplasmic accumulation of HIV-1 vif, vpr, and env/vpu 2 RNAs.Genes Dev1991https://conductscience.org/library/papers/1827422PubMed

See all 42 referencesDownload CSV of references

Cited by24

The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 69 citations.

PMIDTitleJournalYearIn PapersSource
23809924Genetic variation and HIV-associated neurologic disease.Adv Virus Res2013https://conductscience.org/library/papers/23809924PubMed
22073298Characterization of a novel type of HIV-1 particle assembly inhibitor using a quantitative luciferase-Vpr packaging-based assay.PLoS One2011https://conductscience.org/library/papers/22073298PubMed
21949789Exposed hydrophobic residues in human immunodeficiency virus type 1 Vpr helix-1 are important for cell cycle arrest and cell death.PLoS One2011https://conductscience.org/library/papers/21949789PubMed
21878626Cooperation between an intrinsically disordered region and a helical segment is required for ubiquitin-independent degradation by the proteasome.J Biol Chem2011https://conductscience.org/library/papers/21878626PubMed
19607724In vitro dynamics of HIV-1 BF intersubtype recombinants genomic regions involved in the regulation of gene expression.Virol J2009https://conductscience.org/library/papers/19607724PubMed
19105849The inhibition of assembly of HIV-1 virus-like particles by 3-O-(3',3'-dimethylsuccinyl) betulinic acid (DSB) is counteracted by Vif and requires its Zinc-binding domain.Virol J2008https://conductscience.org/library/papers/19105849PubMed
18721481A comprehensive analysis of the naturally occurring polymorphisms in HIV-1 Vpr: potential impact on CTL epitopes.Virol J2008https://conductscience.org/library/papers/18721481PubMed
17553868
Proline 35 of human immunodeficiency virus type 1 (HIV-1) Vpr regulates the integrity of the N-terminal helix and the incorporation of Vpr into virus particles and supports the replication of R5-tropic HIV-1 in human lymphoid tissue ex vivo.
J Virol2007https://conductscience.org/library/papers/17553868PubMed
12388729The first HxRxG motif in simian immunodeficiency virus mac239 Vpr is crucial for G(2)/M cell cycle arrest.J Virol2002https://conductscience.org/library/papers/12388729PubMed
11044109Functional role of residues corresponding to helical domain II (amino acids 35 to 46) of human immunodeficiency virus type 1 Vpr.J Virol2000https://conductscience.org/library/papers/11044109PubMed
10921877Human immunodeficiency virus type 1 Vpr-mediated G(2) cell cycle arrest: Vpr interferes with cell cycle signaling cascades by interacting with the B subunit of serine/threonine protein phosphatase 2A.EMBO J2000https://conductscience.org/library/papers/10921877PubMed
10888660Two putative alpha-helical domains of human immunodeficiency virus type 1 Vpr mediate nuclear localization by at least two mechanisms.J Virol2000https://conductscience.org/library/papers/10888660PubMed
10888643The interaction of vpr with uracil DNA glycosylase modulates the human immunodeficiency virus type 1 In vivo mutation rate.J Virol2000https://conductscience.org/library/papers/10888643PubMed
10505122Suppression of HIV-1 transcription and replication by a Vpr mutant.Gene Ther1999https://conductscience.org/library/papers/10505122PubMed
10490769HIV-1 Vpr-chloramphenicol acetyltransferase fusion proteins: sequence requirement for virion incorporation and analysis of antiviral effect.Gene Ther1999https://conductscience.org/library/papers/10490769PubMed
10196319The amino-terminal region of Vpr from human immunodeficiency virus type 1 forms ion channels and kills neurons.J Virol1999https://conductscience.org/library/papers/10196319PubMed
10074177Mutational analysis of Vpr-induced G2 arrest, nuclear localization, and cell death in fission yeast.J Virol1999https://conductscience.org/library/papers/10074177PubMed
9847364Interaction with the p6 domain of the gag precursor mediates incorporation into virions of Vpr and Vpx proteins from primate lentiviruses.J Virol1999https://conductscience.org/library/papers/9847364PubMed
9261351Nuclear import, virion incorporation, and cell cycle arrest/differentiation are mediated by distinct functional domains of human immunodeficiency virus type 1 Vpr.J Virol1997https://conductscience.org/library/papers/9261351PubMed
9096396Development of a novel anti-HIV-1 agent from within: effect of chimeric Vpr-containing protease cleavage site residues on virus replication.Proc Natl Acad Sci U S A1997https://conductscience.org/library/papers/9096396PubMed

See all 24 cited byDownload CSV of cited by

Data dates

The date of each source this release read.

PubMed
2026-11-06
PubMed
iCite
2026-11-05
iCite
PMC's ID file
2026-11-05
PMC's ID file
NIH RePORTER's grant and paper links
2026-11-01
NIH RePORTER's grant and paper links
Trials
2026-11-12
Gene search
2026-11-11
Pipelines
2026-09-18

None in this release

  • Trials
  • Comments and corrections
  • Genes
  • Drugs
  • Data

Sources 11

  • ChEMBL, through Open TargetsCC BY-SA 3.0
  • ClinicalTrials.govNo license stated
  • HGNCCC0
  • iCiteCC BY 4.0
  • NCBI GenePublic domain (US government)
  • NIH RePORTER's grant and paper linksPublic domain
  • Open TargetsCC0 1.0
  • PMC's ID filePublic domain (US government)
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0
Each source's terms
  • ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • ClinicalTrials.govnone stated
  • HGNCCC0: https://www.genenames.org/about/license/
  • iCiteCC BY 4.0
  • NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
  • Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this paper from software.

The record and each of its lists are JSON, twenty rows a page. No key.

GET https://conductscience.org/api/papers/v1/7731985

GET https://conductscience.org/api/papers/v1/7731985/references?page=2